Pharma Surge

Pharma Surge

🌍·Jan 1, 1970Research

Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial

Publisher

C
Contemporary Clinical Trials

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Contemporary Clinical Trials
Region
Global
Scope
Research
Published
January 1, 1970

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on sciencedirect.com

Leave the platform to read the original full article on the publisher site.

Source: Contemporary Clinical Trials

Scope: Research

Open original article
Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial | Pharma Surge